Comerica Bank cut its stake in shares of UnitedHealth Group Inc (NYSE:UNH) by 0.7% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 272,080 shares of the healthcare conglomerate’s stock after selling 1,943 shares during the period. Comerica Bank’s holdings in UnitedHealth Group were worth $66,618,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in UNH. KBC Group NV lifted its position in shares of UnitedHealth Group by 4.7% in the third quarter. KBC Group NV now owns 323,799 shares of the healthcare conglomerate’s stock valued at $63,416,000 after acquiring an additional 14,672 shares in the last quarter. DekaBank Deutsche Girozentrale lifted its position in shares of UnitedHealth Group by 2.0% in the third quarter. DekaBank Deutsche Girozentrale now owns 489,647 shares of the healthcare conglomerate’s stock valued at $95,646,000 after acquiring an additional 9,810 shares in the last quarter. Bainco International Investors lifted its position in shares of UnitedHealth Group by 5.4% in the third quarter. Bainco International Investors now owns 82,676 shares of the healthcare conglomerate’s stock valued at $16,192,000 after acquiring an additional 4,202 shares in the last quarter. Toronto Dominion Bank lifted its position in shares of UnitedHealth Group by 69.1% in the third quarter. Toronto Dominion Bank now owns 383,943 shares of the healthcare conglomerate’s stock valued at $75,193,000 after acquiring an additional 156,892 shares in the last quarter. Finally, Norinchukin Bank The lifted its position in shares of UnitedHealth Group by 2.7% in the third quarter. Norinchukin Bank The now owns 180,773 shares of the healthcare conglomerate’s stock valued at $35,405,000 after acquiring an additional 4,838 shares in the last quarter. Institutional investors own 86.78% of the company’s stock.
Several equities analysts have recently commented on the company. Credit Suisse Group restated a “buy” rating on shares of UnitedHealth Group in a research report on Friday, March 9th. Wells Fargo restated an “outperform” rating and issued a $245.00 price objective (up from $230.00) on shares of UnitedHealth Group in a research report on Wednesday, November 29th. Citigroup boosted their price objective on UnitedHealth Group from $235.00 to $268.00 and gave the company a “buy” rating in a research report on Wednesday, January 17th. Oppenheimer boosted their price objective on UnitedHealth Group from $260.00 to $240.00 and gave the company an “outperform” rating in a research report on Wednesday, January 17th. Finally, Piper Jaffray Companies boosted their price objective on UnitedHealth Group to $242.00 and gave the company an “overweight” rating in a research report on Wednesday, November 29th. Three investment analysts have rated the stock with a hold rating and twenty-five have issued a buy rating to the company’s stock. UnitedHealth Group has an average rating of “Buy” and an average target price of $245.14.
In other news, CEO Steven H. Nelson sold 14,233 shares of the company’s stock in a transaction that occurred on Thursday, March 15th. The stock was sold at an average price of $230.22, for a total transaction of $3,276,721.26. Following the transaction, the chief executive officer now owns 18,219 shares of the company’s stock, valued at $4,194,378.18. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Kenneth Irwin Shine sold 198 shares of the company’s stock in a transaction that occurred on Friday, January 19th. The shares were sold at an average price of $242.55, for a total value of $48,024.90. Following the transaction, the director now directly owns 1,790,567 shares in the company, valued at approximately $434,302,025.85. The disclosure for this sale can be found here. Insiders have sold 67,015 shares of company stock worth $15,635,599 over the last three months. 0.89% of the stock is currently owned by insiders.
Shares of UNH stock traded down $1.06 during midday trading on Wednesday, reaching $225.72. The company’s stock had a trading volume of 680,755 shares, compared to its average volume of 3,842,992. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.58. UnitedHealth Group Inc has a 52 week low of $162.74 and a 52 week high of $250.79. The company has a market capitalization of $217,772.55, a PE ratio of 21.12, a P/E/G ratio of 1.31 and a beta of 0.74.
UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, January 16th. The healthcare conglomerate reported $2.59 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $2.50 by $0.09. UnitedHealth Group had a return on equity of 21.29% and a net margin of 5.25%. The company had revenue of $52.06 billion for the quarter, compared to analysts’ expectations of $51.57 billion. During the same period in the previous year, the firm posted $2.11 earnings per share. The firm’s revenue for the quarter was up 9.5% on a year-over-year basis. equities analysts predict that UnitedHealth Group Inc will post 12.51 EPS for the current year.
The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 20th. Shareholders of record on Friday, March 9th were paid a dividend of $0.75 per share. The ex-dividend date of this dividend was Thursday, March 8th. This represents a $3.00 annualized dividend and a yield of 1.33%. UnitedHealth Group’s payout ratio is currently 28.01%.
TRADEMARK VIOLATION NOTICE: “Comerica Bank Has $66.62 Million Stake in UnitedHealth Group Inc (UNH)” was originally reported by The Ledger Gazette and is the property of of The Ledger Gazette. If you are reading this piece of content on another site, it was stolen and republished in violation of US & international trademark and copyright law. The original version of this piece of content can be viewed at https://ledgergazette.com/2018/03/21/comerica-bank-has-66-62-million-holdings-in-unitedhealth-group-inc-unh.html.
About UnitedHealth Group
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.